Assessment of dysarthria with Frenchay dysarthria assessment (FDA-2) in patients with Duchenne muscular dystrophy

References

• Birnkrant DJ, Bushby K, Bann CM, et al.; DMD Care Considerations Working Group. Diagnosis and management of Duchenne muscular dystrophy, part 3: primary care, emergency management, psychosocial care, and transitions of care across the lifespan. Lancet Neurol. 2018;17(5):445–455.
   PubMed Web of Science ®Google Scholar
• Yorkston KM. The degenerative dysarthrias: a window into critical clinical and research issues. Folia Phoniatr Logop. 2007;59(3):107–117.
   PubMed Web of Science ®Google Scholar
• Mitchell C, Bowen A, Tyson S, et al. Interventions for dysarthria due to stroke and other adult-acquired, non-progressive brain injury. Cochrane Database Syst Rev. 2017;1(1):1–61.
   Google Scholar
• Bushby K, Finkel R, Birnkrant DJ, et al.; DMD Care Considerations Working Group. Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care. Lancet Neurol. 2010;9(2):177–189.
   PubMed Web of Science ®Google Scholar
• Darley FL, Aronson AE, Brown JR. Differential diagnostic patterns of dysarthria. J Speech Hear Res. 1969;12(2):246–269.
   PubMedGoogle Scholar
• Darley FL, Aronson AE, Brown JR. Clusters of deviant speech dimensions in the dysarthrias. J Speech Hear Res. 1969;12(3):462–496.
   PubMedGoogle Scholar
• Zyski BJ, Weisiger BE. Identification of dysarthria types based on perceptual analysis. J Commun Disord. 1987;20(5):367–378.
   PubMed Web of Science ®Google Scholar
• Enderby P. Frenchay dysarthria assessment. Int J Lang Commun Disord. 1980;15(3):165–173.
   Google Scholar
• Enderby P, Palmer R. Frenchay dysarthria assessment–Second edition (FDA-2). Austin, TX: Pro-ed; 2008.
   Google Scholar
• Cardoso R, Guimarães I, Santos H, et al. Frenchay dysarthria assessment (FDA-2) in Parkinson’s disease: cross-cultural adaptation and psychometric properties of the European Portuguese version. J Neurol. 2017;264(1):21–31.
   PubMed Web of Science ®Google Scholar
• Eigentler A, Rhomberg J, Nachbauer W, et al. The scale for the assessment and rating of ataxia correlates with dysarthria assessment in Friedreich's ataxia. J Neurol. 2012;259(3):420–426.
   PubMed Web of Science ®Google Scholar
• Miller RG, Munsat TL, Swash M, et al. Consensus guidelines for the design and implementation of clinical trials in ALS. J Neurol Sci. 1999;169(1–2):2–12.
   PubMed Web of Science ®Google Scholar
• Beaton DE, Bombardier C, Guillemin F, et al. Guidelines for the process of cross-cultural adaptation of self-report measures. Spine. 2000;25(24):3186–3191.
   PubMed Web of Science ®Google Scholar
• Amano S, Kondo T. On the NTT psycholinguistic databases ‘lexical properties of Japanese’. J Phonetic Soc Jpn. 2000;4(2):44–50.
   Google Scholar
• Mokkink LB, Terwee CB, Patrick DL, et al. The COSMIN study reached international consensus on taxonomy, terminology, and definitions of measurement properties for health-related patient-reported outcomes. J Clin Epidemiol. 2010;63(7):737–745.
   PubMed Web of Science ®Google Scholar
• Ponterotto JG, Ruckdeschel DE. An overview of coefficient alpha and a reliability matrix for estimating adequacy of internal consistency coefficients with psychological research measures. Percept Mot Skills. 2007;105(3 Pt 1):997–1014.
   PubMed Web of Science ®Google Scholar
• Streiner DL, Norman GR, Cairney J. Health measurement scales: a practical guide to their development and use. New York: Oxford University Press; 2015.
   Google Scholar
• Byrne Barbara M. Structural equation modeling with AMOS: Basic concepts, applications, and programming. New York: Routledge; 2016.
   Google Scholar
• Mokkink LB, Prinsen CA, Patrick DL, et al. COSMIN Study Design checklist for Patient-reported outcome measurement instruments. [cited 2019 July]:[1–32 p.]. Available from: https://www.cosmin.nl/.
   Google Scholar
• Swinyard CA, Deaver GG, Greenspan L. Gradients of functional ability of importance in rehabilitation of patients with progressive muscular and neuromuscular diseases. Arch Phys Med Rehabil. 1957;38(9):574–579.
   PubMedGoogle Scholar
• Wada A, Kawakami M, Liu M, et al. Development of a new scale for dysphagia in patients with progressive neuromuscular diseases: the Neuromuscular Disease Swallowing Status Scale (NdSSS). J Neurol. 2015;262(10):2225–2231.
   PubMed Web of Science ®Google Scholar
• Yamada Y, Kawakami M, Wada A, et al. Long-term follow-up of dysphagia in adult patients with Duchenne muscular dystrophy. Eur J Paediatr Neurol. 2018;22(5):786–790.
   Web of Science ®Google Scholar
• Enderby P. Relationships between dysarthric groups. Br J Disord Commun. 1986;21(2):189–197.
   PubMedGoogle Scholar
• J R D. Motor speech disorders: substrates, differential diagnosis, and management. 3rd ed. St. Louis (MO): Elsevier Health Sciences; 2012.
   Google Scholar
• Van Den Engel-Hoek L, Erasmus CE, Hendriks JC, et al. Oral muscles are progressively affected in Duchenne muscular dystrophy: implications for dysphagia treatment. J Neurol. 2013;260(5):1295–1303.
   PubMed Web of Science ®Google Scholar
• Yorkston KM, Honsinger MJ, Mitsuda PM, et al. The relationship between speech and swallowing disorders in head-injured patients. J Head Trauma Rehabil. 1989;4(4):1–16.
   Google Scholar
• Hoit JD, Banzett RB, Lohmeier HL, et al. Clinical ventilator adjustments that improve speech. Chest. 2003;124(4):1512–1521.
   PubMed Web of Science ®Google Scholar
• Liu M, Mineo K, Hanayama K, et al. Practical problems and management of seating through the clinical stages of Duchenne’s muscular dystrophy. Arch Phys Med Rehabil. 2003;84(6):818–824.
   PubMed Web of Science ®Google Scholar
• Hanayama K, Liu M, Higuchi Y, et al. Dysphagia in patients with Duchenne muscular dystrophy evaluated with a questionnaire and videofluorography. Disabil Rehabil. 2008;30(7):517–522.
   PubMed Web of Science ®Google Scholar
• Gayraud J, Ramonatxo M, Rivier F, et al. Ventilatory parameters and maximal respiratory pressure changes with age in Duchenne muscular dystrophy patients. Pediatr Pulmonol. 2010;45(6):552–559.
   PubMed Web of Science ®Google Scholar
• Finsterer J, Stöllberger C. The heart in human dystrophinopathies. Cardiology. 2003;99(1):1–19.
   PubMed Web of Science ®Google Scholar
• Nishio M, Hoshi K, Sakurai M, et al. Clinical management of dysarthria with dysphagia. The Japan Journal of Logopedics and Phoniatrics. 1995;36(2):206–217.
   Google Scholar
• Wang BJ, Carter FL, Altman KW. Relationship between dysarthria and oral-oropharyngeal dysphagia: The current evidence. Ear Nose Throat J. 2018;97(3):E1–E9.
   PubMedGoogle Scholar
• Da Costa Franceschini A, Mourao LF. Dysarthria and dysphagia in amyotrophic lateral sclerosis with spinal onset: a study of quality of life related to swallowing. NRE. 2015;36(1):127–134.
   Web of Science ®Google Scholar
• Perez-Lloret S, Nègre-Pagès L, Ojero-Senard A, et al.; COPARK Study Group. Oro-buccal symptoms (dysphagia, dysarthria, and sialorrhea) in patients with Parkinson's disease: preliminary analysis from the French COPARK cohort. Eur J Neurol. 2012;19(1):28–37.
   PubMed Web of Science ®Google Scholar
• Bach JR, Alba AS. Tracheostomy ventilation. A study of efficacy with deflated cuffs and cuffless tubes. Chest. 1990;97(3):679–683.
   PubMed Web of Science ®Google Scholar
• Shinoe T, Kawai M. Tracheal deformity observed in tracheostomized Duchenne muscular dystrophy patients who can speak with appropriately inflated cuff of tracheal tube. Rinsho Shinkeigaku. 1996;36(2):355–357.
   PubMedGoogle Scholar
• Finder JD, Birnkrant D, Carl J, et al.; American Thoracic Society. Respiratory care of the patient with Duchenne muscular dystrophy: ATS consensus statement. Am J Respir Crit Care Med. 2004;170(4):456–465.
   PubMed Web of Science ®Google Scholar